person

Pablo G. P.

Country
Spain
Department
Cardiology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
191
Sites with multiple studies

Has run more than one trial at 191 of 361 partner sites.

Specializations

Cardiomyopathy Research

The investigator specializes in various forms of cardiomyopathy, with particular focus on hypertrophic cardiomyopathy in both obstructive and non-obstructive forms. Their research extends to evaluating innovative treatments including mavacamten, aficamten, and danicamtiv.

  • Obstructive Hypertrophic Cardiomyopathy (HCM)
  • Non-obstructive HCM
  • Dilated Cardiomyopathy (DCM)

The research includes evaluation of cardiac structure changes and genetic aspects of cardiomyopathy.

Amyloidosis Studies

Extensive research focuses on transthyretin amyloidosis and its cardiac manifestations. The investigator studies multiple therapeutic approaches including ALXN2220, acoramidis, and eplontersen for ATTR-CM.

  • Transthyretin Amyloid Cardiomyopathy
  • Hereditary Transthyretin Amyloidosis
  • Cardiac AL Amyloidosis

Research includes diagnostic imaging studies and novel therapeutic interventions.

Heart Failure Research

The investigator conducts research in various types of heart failure, including studies on heart failure with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF).

  • Heart Failure with Preserved Ejection Fraction
  • Heart Failure with Reduced Ejection Fraction
  • Cardiovascular Clinical Events

Studies include evaluation of novel therapeutic compounds and their impact on cardiac function.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.